Scholars Central

Research articlePublished 13 Nov 2011

Obtaining of SiO2 Nanostructured Materials for Local Drug Delivery of Methotrexate.

Authors: López T, Alvarez M, Arroyo S, Sánchez A, Rembao D, López R

Depto. de Atención a la Salud, Universidad Autónoma Metropolitana-Xochimilco, Calz. Del Hueso, Col. Villa Quietud, Tlalpan, México, DF; Laboratorio de Nanotecnología, Instituto Nacional de Neurología y Neurocirugía “MVS”. Insurgentes Sur, Col. La Fama, Tlalpan, México; Laboratorio de Neuropatología, Instituto Nacional de Neurología y Neurocirugía “MVS”. Insurgentes Sur, Col. La Fama, Tlalpan, México; Laboratorio de Patología Experimental, Instituto Nacional de Neurología y Neurocirugía “MVS”. Insurgentes Sur, Col. La Fama, Tlalpan, México; Department of Chemical and Biomolecular Engineering, Tulane University, New Orleans, LA USA; Escuela Superior de Medicina. Instituto Politécnico Nacional. Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo Tomas, Delegación Miguel Hidalgo, México, DF

Journal of Biotechnology & Biomaterials

Volume 3 · Issue 2 · Pages 1–10

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Local delivery of drugs has become an alternative to overcome several side effects of conventional drug administration methods. Because of their novel properties, nanomaterials for controlled drug release have shown enormous potential in the treatment of cancer. In the present work a chemotherapeutic agent, methotrexate (MTX) was encapsulated into a sol-gel SiO2 matrix, as a reservoir for local controlled release in the treatment of a solid brain tumor like Glioblastoma Multiforme (GBM) in an animal model. In order to study interactions between the drug and the SiO2, several physicochemical characterization techniques were carried out. FTIR spectroscopy showed evidence drug incorporation into the silica matrix as the presence of bands at 1504 cm-1, 1604 cm-1 and 1637 cm-1 reveals. This is supported by UV-Vis results, since silica spectrum acquired new features. The materials are mesoporous with a mean pore diameter about 78 Å. In vitro drug release was performed by UV-Vis spectroscopy following the main absorption band of MTX at 348 nm. Drug release was followed and monitored by 16 days. For in vivo evaluation GBM model was performed in Wistar rats once the tumor was developed a reservoir was placed by stereotactic surgery. After three months of tumor inoculation animals treated with MTX-SiO2 survived while in those untreated survival did not exceed 30 days.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Biotechnology & Biomaterials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biotechnology & Biomaterials
  • SubjectBiochemistry & Biotechnology
  • SubjectMaterials Science
  • BylineArticles whose byline prints “López T”
  • BylineArticles whose byline prints “Alvarez M”
  • BylineArticles whose byline prints “Arroyo S”
  • BylineArticles whose byline prints “Sánchez A”
  • BylineArticles whose byline prints “Rembao D”
  • BylineArticles whose byline prints “López R”